These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9242819)
21. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Sartwell PE; Masi AT; Arthes FG; Greene GR; Smith HE Am J Epidemiol; 1969 Nov; 90(5):365-80. PubMed ID: 5395236 [No Abstract] [Full Text] [Related]
22. Postoperative thromboembolism and the use of oral contraceptives. Vessey MP; Doll R; Fairbairn AS; Glober G Br Med J; 1970 Jul; 3(5715):123-6. PubMed ID: 5431081 [TBL] [Abstract][Full Text] [Related]
25. Some methodological problems in the investigation of rare adverse reactions to oral contraceptives. Vessey MP Am J Epidemiol; 1971 Sep; 94(3):202-9. PubMed ID: 5093651 [No Abstract] [Full Text] [Related]
27. [The pill and thromboembolism. 1. Thrombogenesis and additional risk factors. A review of the literature]. Herzog C; Mall-Haefeli M Ther Ggw; 1979 Oct; 118(10):1550-74. PubMed ID: 386549 [No Abstract] [Full Text] [Related]
28. [Thromboembolism during oral contraception. A critical review of the literature]. Dalgaard JB; Gregersen M Nord Med; 1968 Nov; 80(45):1509-15. PubMed ID: 4884843 [No Abstract] [Full Text] [Related]
30. An analysis of the reported association of oral contraceptives to thromboembolic disease. Odell WD West J Med; 1975 Jan; 122(1):26-33. PubMed ID: 1089003 [No Abstract] [Full Text] [Related]
31. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419 [TBL] [Abstract][Full Text] [Related]
32. [Hormonal contraception and blood coagulation disorders]. Schander K; Plotz EJ Med Klin; 1974 Feb; 69(7):265-71. PubMed ID: 4596111 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of thrombosis due to oral contraceptives: a further report. Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873 [TBL] [Abstract][Full Text] [Related]
34. [Reporting of adverse drug reactions to the Norwegian Drug Control Agency]. Skjeldestad FE; Amundsen T; Høibraaten E Tidsskr Nor Laegeforen; 2000 Jan; 120(3):336-8. PubMed ID: 10827524 [TBL] [Abstract][Full Text] [Related]
35. [Significance of pharmacoepidemiology for drug monitoring and quality of care: the pill]. Stricker BH; Rosendaal FR Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2541-3. PubMed ID: 8657314 [No Abstract] [Full Text] [Related]
36. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Vessey MP; Doll R Br Med J; 1969 Jun; 2(5658):651-7. PubMed ID: 5783122 [TBL] [Abstract][Full Text] [Related]
38. The use of rodents for studies of toxicity in contraceptive research. Leonard BJ Acta Endocrinol Suppl (Copenh); 1974; 185():34-73. PubMed ID: 4593797 [No Abstract] [Full Text] [Related]
39. End of the line for "third-generation-pill" controversy? Vandenbroucke JP; Rosendaal FR Lancet; 1997 Apr; 349(9059):1113-4. PubMed ID: 9113005 [TBL] [Abstract][Full Text] [Related]
40. Pulmonary embolism and oral steroidal contraceptives. Hobel CJ; Mishell DR Am J Obstet Gynecol; 1968 Aug; 101(7):994-6. PubMed ID: 5659958 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]